QuidelOrtho Corporation QDEL
10.94
0.25
2.34%
as of 25 Sep
- Market cap
- $733.1M
- P/E
- 0.0×
Follow QDEL
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (45.91%) | (49.95%) | (46.15%) | (45.16%) |
+8 more TTM periods Free account |
|
| (17.34%) | (20.03%) | (18.56%) | (18.91%) | ||
ROIC |
(11.35%) | (13.97%) | (13.05%) | (12.96%) | |
Return on Tangible Assets |
(60.89%) | (69.04%) | (61.53%) | (61.37%) | |
Average Days of Receivables |
48.04 | 49.44 | 55.75 | 51.97 | |
Free Cash Flow per Share |
(3.09) | (2.34) | (1.22) | (2.11) | |
Free Cash Flow |
(211.20) | (159.40) | (83.00) | (143.80) | |
Capital Expenditures |
(154.00) | (166.00) | (188.20) | (180.80) | |
Piotroski F-Score |
3.00 | 4.00 | 6.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(1.19%) | 0.14% | 2.22% | 0.77% | |
Accounts Receivable Turnover |
8.53 | 8.23 | 7.81 | 7.97 | |
Accounts Payable Turnover |
6.51 | 6.17 | 5.54 | 6.22 | |
Inventory Turnover |
2.47 | 2.49 | 2.62 | 2.41 | |
Average Days of Payables |
58.27 | 60.77 | 70.04 | 54.37 | |
Days of Inventory on Hand |
152.48 | 152.61 | 144.80 | 156.18 | |
Tax Rate |
0.02 | 0.03 | 0.02 | 0.04 | |
Research and Development Expense of Revenue |
6.76% | 6.70% | 6.82% | 6.91% | |
Selling, General and Administrative Expense of Revenue |
28.80% | 28.55% | 27.33% | 27.24% | |
Share Based Compensation of Revenue |
1.65% | 1.69% | 1.68% | 1.65% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.05 | (0.01) | (0.09) | (0.03) | |
Depreciation/Fixed assets |
0.87 | 0.86 | 0.84 | 0.92 | |
Capex/Depreciation |
(0.13) | (0.14) | (0.16) | (0.15) | |
Revenue per Share |
39.15 | 38.96 | 40.27 | 39.92 | |
Operating CF per Share |
(0.84) | 0.10 | 1.55 | 0.54 | |
Capex per Share |
(2.25) | (2.43) | (2.78) | (2.66) | |
Capex to Sales |
0.06 | 0.06 | 0.07 | 0.07 | |
Net Profit Margin |
(39.20%) | (45.57%) | (41.45%) | (43.45%) |
Columns are period end dates